Bard Associates Inc. Acquires 224 Shares of Utah Medical Products, Inc. (NASDAQ:UTMD)

Bard Associates Inc. lifted its stake in shares of Utah Medical Products, Inc. (NASDAQ:UTMD) by 1.1% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 19,781 shares of the medical instruments supplier’s stock after acquiring an additional 224 shares during the quarter. Bard Associates Inc.’s holdings in Utah Medical Products were worth $1,329,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. Copeland Capital Management LLC purchased a new position in shares of Utah Medical Products during the 3rd quarter valued at approximately $53,000. Rhumbline Advisers increased its position in shares of Utah Medical Products by 17.3% in the second quarter. Rhumbline Advisers now owns 5,508 shares of the medical instruments supplier’s stock valued at $368,000 after buying an additional 812 shares in the last quarter. Cardinal Capital Management lifted its position in shares of Utah Medical Products by 6.2% during the 2nd quarter. Cardinal Capital Management now owns 15,645 shares of the medical instruments supplier’s stock valued at $1,050,000 after buying an additional 908 shares in the last quarter. Price T Rowe Associates Inc. MD lifted its position in shares of Utah Medical Products by 4.3% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 22,941 shares of the medical instruments supplier’s stock valued at $1,632,000 after buying an additional 947 shares in the last quarter. Finally, Allspring Global Investments Holdings LLC purchased a new position in Utah Medical Products during the second quarter valued at $83,000. 69.60% of the stock is currently owned by hedge funds and other institutional investors.

Utah Medical Products Trading Down 0.7 %

UTMD stock opened at $66.52 on Friday. The firm has a 50-day moving average of $66.03 and a two-hundred day moving average of $67.34. The company has a market cap of $225.50 million, a price-to-earnings ratio of 15.58 and a beta of 0.08. Utah Medical Products, Inc. has a 12 month low of $63.38 and a 12 month high of $87.86.

Utah Medical Products Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 3rd. Investors of record on Monday, December 16th will be issued a $0.305 dividend. The ex-dividend date of this dividend is Monday, December 16th. This is a boost from Utah Medical Products’s previous quarterly dividend of $0.30. This represents a $1.22 dividend on an annualized basis and a yield of 1.83%. Utah Medical Products’s dividend payout ratio is currently 28.10%.

Analysts Set New Price Targets

Separately, StockNews.com lowered Utah Medical Products from a “strong-buy” rating to a “buy” rating in a research note on Thursday, November 7th.

Utah Medical Products Company Profile

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.